Moran Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-132,336
Closed -$8.3M 496
2026
Q1
$8.3M Sell
132,336
-49,998
-27% -$4M 0.25% 137
2025
Q4
$17.4M Sell
182,334
-5,781
-3% -$567K 0.53% 54
2025
Q3
$18.4M Sell
188,115
-7,301
-4% -$756K 0.55% 50
2025
Q2
$21M Sell
195,416
-958
-0.5% -$96.9K 0.65% 38
2025
Q1
$19.8M Sell
196,374
-3,250
-2% -$327K 0.67% 39
2024
Q4
$17.8M Buy
199,624
+623
+0.3% +$54.8K 0.57% 54
2024
Q3
$16.7M Buy
199,001
+160,311
+414% +$12.6M 0.51% 69
2024
Q2
$2.98M Buy
+38,690
New +$2.83M 0.1% 221

Other funds holding BSX

Moran Wealth Management's BSX Position: Q2 2026 in Review

Moran Wealth Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 132,336 shares — an estimated $8.3M sold.

Moran Wealth Management first reported a position in BSX in Q2 2024 and held it in 8 quarters. The position peaked at $21M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Moran Wealth Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Moran Wealth Management sold 132,336 Boston Scientific shares in Q2 2026, an estimated $8.3M.
  • Moran Wealth Management first reported a position in Boston Scientific in Q2 2024 and held it in 8 quarters.
  • Moran Wealth Management's Boston Scientific position peaked at $21M in Q2 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Moran Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.